Pelubiprofen CR Tablet (Controlled Release)
制剂 FDF · Tablet · 45mg, twice daily
制剂 FDFConfidentiality：公开
- INN / Generic Name
- Pelubiprofen CR Tablet (Controlled Release)
- Dosage Form
- Tablet
- Strength
- 45mg, twice daily
- Therapy Area
- Others > Rheumatology
- Indication
- Pain; Osteoarthritis; Low back pain; Rheumatoid arthritis
- Current Status
- 官方 FDF 授权目录（UB417）
- GMP Certification
- KR - MFDS
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- 已完成注册（目标市场可转移 / 视市场 DCP·NP）
- MOQ
- 询价
- Lead Time
- 询价
- Price Range
- 询价
Registrable Markets
South Korea
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price
- —